BUENA, N.J., June 21, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the JMP Securities Life Sciences Conference. The Conference will take place June 21-22, 2016 at The St. Regis New York, New York, NY.
Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Tuesday, June 21, 2016 at 12:00 p.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 90 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact: Jenniffer Collins
Teligent, Inc.
(856) 697-4379
www.teligent.com
Logo - http://photos.prnewswire.com/prnh/20151022/279641LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-present-at-jmp-securities-life-sciences-conference-on-june-21-2016-300287600.html
SOURCE Teligent, Inc.
